Cullinan Therapeutics Files 8-K on Security Holder Votes

Ticker: CGEM · Form: 8-K · Filed: Jun 12, 2025 · CIK: 1789972

Cullinan Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyCullinan Therapeutics, Inc. (CGEM)
Form Type8-K
Filed DateJun 12, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote, sec-filing

Related Tickers: CLN

TL;DR

Cullinan Therapeutics (CLN) filed an 8-K for shareholder votes on June 12, 2025.

AI Summary

Cullinan Therapeutics, Inc. filed an 8-K on June 12, 2025, to report on matters submitted to a vote of its security holders. The filing indicates a change in the company's reporting status or a significant corporate event requiring disclosure.

Why It Matters

This filing is important as it signals a corporate action or decision that has been put to a vote by the company's shareholders, potentially impacting the company's direction or governance.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a vote by security holders and does not inherently indicate negative financial or operational news.

Key Players & Entities

  • Cullinan Therapeutics, Inc. (company) — Registrant
  • June 12, 2025 (date) — Date of Report
  • 001-39856 (company) — Commission File Number
  • 81-3879991 (company) — IRS Employer Identification No.
  • One Main Street Suite 1350 (location) — Principal Executive Offices Address
  • Cambridge, Massachusetts (location) — Principal Executive Offices City and State
  • 02142 (location) — Principal Executive Offices Zip Code

FAQ

What specific matters were submitted to a vote of Cullinan Therapeutics' security holders?

The provided text does not specify the exact matters submitted to a vote, only that such matters were reported in the 8-K filing.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on June 12, 2025.

What is Cullinan Therapeutics, Inc.'s Commission File Number?

Cullinan Therapeutics, Inc.'s Commission File Number is 001-39856.

What is the IRS Employer Identification Number for Cullinan Therapeutics, Inc.?

The IRS Employer Identification Number for Cullinan Therapeutics, Inc. is 81-3879991.

Where are Cullinan Therapeutics, Inc.'s principal executive offices located?

Cullinan Therapeutics, Inc.'s principal executive offices are located at One Main Street, Suite 1350, Cambridge, Massachusetts, 02142.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Cullinan Therapeutics, Inc. (CGEM).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.